studia universitatis babeÅ-bolyai biologia 2
studia universitatis babeÅ-bolyai biologia 2
studia universitatis babeÅ-bolyai biologia 2
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
C. PAŞCA et al.<br />
Cisplatin (Platinol, cis-DDP) is a platinum compound belonging to the<br />
alkylating agents, successfully applied in the chemotherapy of several types of<br />
cancer. The antineoplasic activity is generally believed to result from the<br />
interaction of the drug with the DNA in the tumour cells, this interaction leading to<br />
the formation of different types of adducts through the reaction of the bifunctional<br />
platinum compound with N7 atoms of the nucleobases guanine and adenine. The<br />
major adducts are intrastrand cross-links formed by the binding of cis-DDP on two<br />
neighbouring guanines, on adenine and guanine, and on two guanines separated by<br />
one or more nucleobases. Other types of adducts formed are the interstrand crosslink<br />
on two guanines and monofunctionally bound cis-DDP. Inside cells, cis-DDP<br />
can form DNA-protein cross-links [6-8]. Cisplatin has a significant hematologic<br />
and nonhematologic toxicity, especially nephrotoxicity. The histological and<br />
ultrastructural modifications induced by this anticancer drug on the rat kidney are<br />
still incompletely known; therefore, our investigations tried to emphasise these aspects<br />
in concordance with the moment of the sacrification after the administration of<br />
some therapeutic doses.<br />
Material and methods. Our experiments were carried out with the following<br />
five groups of healthy adult male Wistar rats, weighing 190 + 10 g and maintained<br />
under bioclimatic laboratory conditions, with no food for 18 hours before the<br />
treatment, but having water ad libitum:<br />
-group U – untreated (control) group;<br />
-group C 1 , C 2 , C 3 and C 4 treated i.v. with 20 mg Cisplatin /m 2 body surface/day,<br />
for three days, and sacrificed 24 hours, 4, 11 and 18 days after the treatment.<br />
The animals were not fed for 18 hours before the sacrification. Having<br />
sacrificed the animals, we took fragments from the kidney. For microscopic<br />
examination the fragments were fixed in 10% neutral formol, processed by the<br />
paraffin technique and the sections of 6 µm were stained by the hematoxylin-eosin,<br />
Masson-Goldner trichrome and PAS methods [12]. For ultrastructural investigations<br />
fragments of kidney were prefixed in 2.7% glutaraldehyde solution and postfixed<br />
in 2% osmic acid solution. The fragments were dehydrated in acetone and then<br />
embedded in Vestopal W. The ultrathin sections were obtained using an LKB III<br />
ultramicrotome and were contrasted with uranyl acetate. Examination of the sections<br />
were performed in a TESLA-BS-500 electron microscope [1, 10, 13].<br />
On the stained and contrasted sections we studied, by light and electron<br />
microscopic examinations, the histological and ultrastructural modifications induced<br />
by this anticancer drug in concordance with the moment of the sacrification.<br />
Results and discussion. The light and electron microscopy investigations<br />
of the kidney sections showed the appearance of some significant modifications<br />
which seemed to be in concordance with the moment of the sacrification.<br />
58